The nuclear receptor Nr4a1 mediates anti-inflammatory effects of apoptotic cells

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4852-4858

  Ipseiz, Natacha ^a,b   Uderhardt, Stefan ^a,b   Scholtysek, Carina ^a,b   Steffen, Martin ^a,b   Schabbauer, Gernot ^c   Bozec, Aline ^a,b   Schett, Georg ^a   Krönke, Gerhard ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 6; NUCLEAR RECEPTOR NUR77; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE DELETION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LUPUS VULGARIS; MACROPHAGE; MOLECULAR DYNAMICS; MONOCYTE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THYMOCYTE;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; INTERLEUKIN-12; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NF-KAPPA B; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; SIGNAL TRANSDUCTION;

EID: 84901267349     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303377     Document Type: Article

References (42)

1. Hochreiter-Hufford, A., and K. S. Ravichandran. 2013. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb. Perspect. Biol. 5: a008748.
2. Munoz, L. E., K. Lauber, M. Schiller, A. A. Manfredi, and M. Herrmann. 2010. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatology 6: 280-289.
3. Erwig, L. P., and P. M. Henson. 2007. Immunological consequences of apoptotic cell phagocytosis. Am. J. Pathol. 171: 2-8.
4. Chawla, A., J. J. Repa, R. M. Evans, and D. J. Mangelsdorf. 2001. Nuclear receptors and lipid physiology: opening the X-files. Science 294: 1866-1870.
5. Bensinger, S. J., and P. Tontonoz. 2008. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454: 470-477.
6. Zhao, Y., and D. Bruemmer. 2010. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler. Thromb. Vasc. Biol. 30: 1535-1541.
7. Pearen, M. A., and G. E. Muscat. 2010. Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol. Endocrinol. 24: 1891-1903.
8. McMorrow, J. P., and E. P. Murphy. 2011. Inflammation: a role for NR4A orphan nuclear receptors?. Biochem. Soc. Trans. 39: 688-693.
9. Hanna, R. N., L. M. Carlin, H. G. Hubbeling, D. Nackiewicz, A. M. Green, J. A. Punt, F. Geissmann, and C. C. Hedrick. 2011. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C2 monocytes. Nat. Immunol. 12: 778-785.
10. Hanna, R. N., I. Shaked, H. G. Hubbeling, J. A. Punt, R. Wu, E. Herrley, C. Zaugg, H. Pei, F. Geissmann, K. Ley, and C. C. Hedrick. 2012. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ. Res. 110: 416-427.
11. Bonta, P. I., H. L. Matlung, M. Vos, S. L. Peters, H. Pannekoek, E. N. Bakker, and C. J. de Vries. 2010. Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels. Cardiovasc. Res. 87: 561-568.
12. Chao, L. C., Z. Zhang, L. Pei, T. Saito, P. Tontonoz, and P. F. Pilch. 2007. Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol. Endocrinol. 21: 2152-2163.
13. Sekiya, T., I. Kashiwagi, N. Inoue, R.Morita, S. Hori, H.Waldmann, A. Y. Rudensky, H. Ichinose, D.Metzger, P. Chambon, and A. Yoshimura. 2011. The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat. Commun. 2: 269.
14. Hamers, A. A., M. Vos, F. Rassam, G. Marinkovic, K. Kurakula, P. J. van Gorp, M. P. de Winther, M. J. Gijbels, V. de Waard, and C. J. de Vries. 2012. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ. Res. 110: 428-438.
15. Hashimoto, D., A. Chow, C. Noizat, P. Teo, M. B. Beasley, M. Leboeuf, C. D. Becker, P. See, J. Price, D. Lucas, et al. 2013. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38: 792-804.
16. Schulz, C., E. Gomez Perdiguero, L. Chorro, H. Szabo-Rogers, N. Cagnard, K. Kierdorf, M. Prinz, B. Wu, S. E. Jacobsen, J. W. Pollard, et al. 2012. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336: 86-90.
17. Yona, S., K. W. Kim, Y. Wolf, A. Mildner, D. Varol, M. Breker, D. Strauss-Ayali, S. Viukov, M. Guilliams, A. Misharin, et al. 2013. Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis. Immunity 38: 79-91.
18. Uderhardt, S., M. Herrmann, O. V. Oskolkova, S. Aschermann, W. Bicker, N. Ipseiz, K. Sarter, B. Frey, T. Rothe, R. Voll, et al. 2012. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 36: 834-846.
19. Wong, K., P. A. Valdez, C. Tan, S. Yeh, J. A. Hongo, and W. Ouyang. 2010. Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages. Proc. Natl. Acad. Sci. USA 107: 8712-8717.
20. Nakayama, M., H. Akiba, K. Takeda, Y. Kojima, M. Hashiguchi, M. Azuma, H. Yagita, and K. Okumura. 2009. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113: 3821-3830.
21. Ravichandran, K. S. 2011. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 35: 445-455.
22. Saijo, K., B. Winner, C. T. Carson, J. G. Collier, L. Boyer, M. G. Rosenfeld, F. H. Gage, and C. K. Glass. 2009. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137: 47-59.
23. Ivashkiv, L. B. 2011. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur. J. Immunol. 41: 2477-2481.
24. Sen, P., M. A. Wallet, Z. Yi, Y. Huang, M. Henderson, C. E. Mathews, H. S. Earp, G. Matsushima, A. S. Baldwin, Jr., and R. M. Tisch. 2007. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 109: 653-660.
25. Satoh, M., H. B. Richards, V. M. Shaheen, H. Yoshida, M. Shaw, J. O. Naim, P. H. Wooley, and W. H. Reeves. 2000. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin. Exp. Immunol. 121: 399-405.
26. Miyake, Y., K. Asano, H. Kaise, M. Uemura, M. Nakayama, and M. Tanaka. 2007. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117: 2268-2278.
27. McGaha, T. L., Y. Chen, B. Ravishankar, N. van Rooijen, and M. C. Karlsson. 2011. Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. Blood 117: 5403-5412.
28. Savill, J., C. Gregory, and C. Haslett. 2003. Cell biology. Eat me or die. Science 302: 1516-1517.
29. Savill, J. S., A. H. Wyllie, J. E. Henson, M. J. Walport, P. M. Henson, and C. Haslett. 1989. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83: 865-875.
30. Hoffmann, P. R., J. A. Kench, A. Vondracek, E. Kruk, D. L. Daleke, M. Jordan, P. Marrack, P. M. Henson, and V. A. Fadok. 2005. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J. Immunol. 174: 1393-1404.
31. Huynh, M. L., V. A. Fadok, and P. M. Henson. 2002. Phosphatidylserinedependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109: 41-50.
32. Scott, R. S., E. J. McMahon, S. M. Pop, E. A. Reap, R. Caricchio, P. L. Cohen, H. S. Earp, and G. K. Matsushima. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207-211.
33. Lu, Q., and G. Lemke. 2001. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293: 306-311.
34. Wallet, M. A., P. Sen, R. R. Flores, Y. Wang, Z. Yi, Y. Huang, C. E. Mathews, H. S. Earp, G. Matsushima, B. Wang, and R. Tisch. 2008. MerTK is required for apoptotic cell-induced T cell tolerance. J. Exp. Med. 205: 219-232.
35. Kobayashi, N., P. Karisola, V. Pena-Cruz, D. M. Dorfman, M. Jinushi, S. E. Umetsu, M. J. Butte, H. Nagumo, I. Chernova, B. Zhu, et al. 2007. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27: 927-940.
36. Miyanishi, M., K. Tada, M. Koike, Y. Uchiyama, T. Kitamura, and S. Nagata. 2007. Identification of Tim4 as a phosphatidylserine receptor. Nature 450: 435-439.
37. Cohen, P. L., R. Caricchio, V. Abraham, T. D. Camenisch, J. C. Jennette, R. A. Roubey, H. S. Earp, G. Matsushima, and E. A. Reap. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196: 135-140.
38. Kim, S., K. B. Elkon, and X. Ma. 2004. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21: 643-653.
39. Reeves,W. H., P. Y. Lee, J. S. Weinstein, M. Satoh, and L. Lu. 2009. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 30: 455-464.
40. Miyanishi, M., K. Segawa, and S. Nagata. 2012. Synergistic effect of Tim4 and MFGE8 null mutations on the development of autoimmunity. Int. Immunol. 24: 551-559.
41. Mukundan, L., J. I. Odegaard, C. R. Morel, J. E. Heredia, J. W. Mwangi, R. R. Ricardo-Gonzalez, Y. P. Goh, A. R. Eagle, S. E. Dunn, J. U. Awakuni, et al. 2009. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat. Med. 15: 1266-1272.
42. A-Gonzalez, N., S. J. Bensinger, C. Hong, S. Beceiro, M. N. Bradley, N. Zelcer, J. Deniz, C. Ramirez, M. Diaz, G. Gallardo, et al. 2009. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31: 245-258.